Immuron Limited Revenue per Employee (IMRN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Immuron Limited  (NASDAQ: IMRN)
 

Immuron Limited's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 55.99% in the fourth quarter 2025, year on year to cumulative value of $7 million, Immuron Limited's revenue per employee grew on a trailing twelve months basis to $ 563,758, this marks a new company high.
Within the Healthcare sector Employees of 249 other companies have achieved higher revenue per employee. While Immuron Limited's total ranking has deteriorated compared to the previous quarter from 0 to 2037. Immuron Limited has 12 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMRN Revenue per Employee (Jun 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
IV. Quarter
Y / Y Revenue Change 55.99 % - - - 192.95 %
Sales per Employee (TTM) $ 563,758 361,400 361,400 361,400 361,400
IMRN's Total Ranking # 2037 # 0 # # #
Seq. Revenue Change - - - - -

IMRN Company Profile >> Back to IMRN Efficiency Comparisons >> Compare IMRN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 128
Healthcare Sector # 250
Overall Market # 2037

Revenue per Employee Statistics
High Average Low
$ 563,758 $ 231,868 $ 12,148
(Jun 30 2025)   (Jun 30 2021)



Financial Statements
Immuron Limited's Revenue MRQ $ 7 Millions Visit IMRN's Income Statement
Immuron Limited's Revenues TTM $ 7 Millions Visit IMRN's aggregate revenue growth
What are IMRN's Sales? Visit IMRN's Sales by Segment




Other Ratios
Immuron Limited's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IMRN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IMRN's Competitors
Revenue per Employee for IMRN's Suppliers
Revenue per Employee for IMRN's Customers

You may also want to know
IMRN's Sales Growth Rates IMRN's Pe Price to earnings ratio IMRN's Receivables Turnover Ratio IMRN's Stock Quote
IMRN's Net Income Growth Rates IMRN's Ps Price to Sales ratio IMRN's Sales per Employee IMRN's Asset Turnover Ratio
IMRN's Net Margin IMRN's Pb Price to Book ratio IMRN's Financial Strength Ratios IMRN's Dividend Payout Ratio
Date modified: 2026-07-07T11:25:07+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2025Number of Employees Jun 30 2025
Alnylam Pharmaceuticals Inc   984,785.20 $ 2,461.963  Million 2,500 
Corcept Therapeutics Inc  980,931.51 $ 716.080  Million 730 
Journey Medical Corp  972,362.07 $ 56.397  Million 58 
Coherus Oncology inc   971,231.29 $ 142.771  Million 147 
Fennec Pharmaceuticals Inc   951,485.71 $ 33.302  Million 35 
Biomarin Pharmaceutical Inc  951,135.67 $ 3,063.608  Million 3,221 
Emergent Biosolutions Inc   946,222.22 $ 851.600  Million 900 
Regeneron Pharmaceuticals Inc   922,401.04 $ 14,214.200  Million 15,410 
Esperion Therapeutics Inc   911,989.80 $ 268.125  Million 294 
Elutia Inc   906,923.08 $ 23.580  Million 26 
Sanara Medtech Inc   891,004.41 $ 96.228  Million 108 
Theravance Biopharma inc   857,833.33 $ 77.205  Million 90 
Pacira Biosciences inc   851,445.11 $ 705.848  Million 829 
Pfizer Inc  851,106.67 $ 63,833.000  Million 75,000 
Merck and Co Inc   848,213.33 $ 63,616.000  Million 75,000 
Carlisle Companies Incorporated  847,762.71 $ 5,001.800  Million 5,900 
Y mabs Therapeutics inc   847,210.00 $ 84.721  Million 100 
Xtant Medical Holdings Inc   846,748.34 $ 127.859  Million 151 
Ispecimen inc   844,011.57 $ 5.908  Million 7 
Masimo Corp  840,090.91 $ 1,848.200  Million 2,200 
Evolus Inc   829,362.28 $ 277.007  Million 334 
Dyadic International Inc   827,015.60 $ 4.135  Million 5 
Hims and Hers Health Inc   824,042.59 $ 2,012.312  Million 2,442 
Arbutus Biopharma Corp  811,368.42 $ 15.416  Million 19 
Tarsus Pharmaceuticals Inc   798,705.41 $ 295.521  Million 370 
Ardelyx inc   789,664.62 $ 386.146  Million 489 
Alector Inc   787,669.90 $ 81.130  Million 103 
Ani Pharmaceuticals Inc  770,514.43 $ 747.399  Million 970 
Sutro Biopharma Inc   762,576.64 $ 104.473  Million 137 
Alphatec Holdings Inc   747,441.40 $ 682.414  Million 913 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.